Molecule

Vancomycin

Also known as vancomycin hydrochloride

Available on requestCold chainAntibiotics Gastroenterology

Presentations: 47
Brands: 3
Manufacturers: 3
Available from stock: 0

Vancomycin is a glycopeptide antibacterial indicated for the treatment of Clostridioides difficile -associated diarrhea, among other approved uses. It is available as powder for injection, injection and capsules for intravenous, oral and intravitreal use. MedsAcross supplies Vancomycin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Key facts

Pharmacological class: Glycopeptide Antibacterial
ATC classification: A07AA09 Vancomycin · Diarrhoea treatments and intestinal anti-inflammatories, subgroup A07A, subgroup A07AAJ01XA01 Vancomycin · Glycopeptide antibiotic
US FDA first approval: 15 April 1986
EU status: Not recorded
Orphan designation: Not recorded
WHO essential medicine: Not recorded
India (CDSCO): Not yet confirmed against CDSCO approval lists
Routes: Intravenous, Oral, Intravitreal
Dosage forms: Powder for injection, Injection, Capsule, Kit, Powder for oral solution, Oral solution
Identifiers: UNII 6Q205EH1VURxCUI 11124CAS 1404-90-6DrugBank DB00512Q424027

Clinical information

From the regulator-approved product information. Each section names its source.

Uses

Vancomycin Hydrochloride Capsules are indicated for the treatment of Clostridioides difficile -associated diarrhea. Vancomycin Hydrochloride Capsules are also used for the treatment of enterocolitis caused by Staphylococcus aureus (including methicillin-resistant strains) in adult and pediatric patients less than 18 years of age. Limitations of Use • Parenteral administration of vancomycin is not effective for the above infections, therefore, Vancomycin Hydrochloride Capsules must be given orally for these infections. • Orally administered Vancomycin Hydrochloride Capsules are not effective for other types of infections.

Source: US FDA prescribing information

How it works

Vancomycin is an antibacterial drug.

Source: US FDA prescribing information

Dosing overview

• C. difficile- associated diarrhea: • Adult Patients (18 years of age or greater): 125 mg orally 4 times daily for 10 days. • Pediatric Patients (less than 18 years of age): 40 mg/kg in 3 or 4 divided doses for 7 to 10 days. The total daily dosage should not exceed 2 g. • Staphylococcal enterocolitis: • Adult Patients (18 years of age or greater): 500 mg to 2 g orally in 3 or 4 divided doses for 7 to 10 days. • Pediatric Patients (less than 18 years of age): 40 mg/kg in 3 or 4 divided doses for 7 to 10 days. The total daily dosage should not exceed 2 g.

Source: US FDA prescribing information

Contraindications

Vancomycin Hydrochloride Capsules are contraindicated in patients with known hypersensitivity to vancomycin. Hypersensitivity to vancomycin

Source: US FDA prescribing information

Warnings and precautions

• Vancomycin Hydrochloride Capsules must be given orally for treatment of staphylococcal enterocolitis and C. difficile -associated diarrhea. Orally administered Vancomycin Hydrochloride Capsules is not effective for other types of infections. • Clinically significant serum concentrations have been reported in some patients who have taken multiple oral doses of Vancomycin Hydrochloride Capsules for active C. difficile -associated diarrhea. Monitoring of serum concentrations may be appropriate in some instances. • Nephrotoxicity has occurred following oral Vancomycin Hydrochloride Capsule therapy and can occur either during or after completion of therapy. The risk is increased in geriatric patients. Monitor renal function. • Ototoxicity has occurred in patients receiving Vancomycin Hydrochloride Capsules. Assessment of auditory function may be appropriate in some instances.

Source: US FDA prescribing information

Side effects

The most common adverse reactions (≥ 10%) were nausea (17%), abdominal pain (15%), and hypokalemia (13%).

Source: US FDA prescribing information

Interactions

No drug interaction studies have been conducted.

Source: US FDA prescribing information

Storage

Store at 20° to 25°C (68° to 77°F), excursions permitted from 15° to 30°C (59° to 86°F).

Source: US FDA prescribing information

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

All presentations

47 presentations of Vancomycin, sorted by availability.

Medicine	Manufacturer	Register	Availability
Vancomycin 500 mg/10 mL powder for injectionIntravenousGeneric name	—	US FDA	Available on request
Vancomycin 250 mg capsuleOralGeneric name	—	US FDA	Available on request
Vancomycin 125 mg capsuleOralGeneric name	—	US FDA	Available on request
Vancomycin 10 g/100 mL powder for injectionIntravenousGeneric name	—	US FDA	Available on request
Vancomycin 250 mg/5 mL powder for oral solutionOral Cold chainGeneric name	—	US FDA	Available on request
Vancomycin 1 g powder for injectionIntravenousGeneric name	—	US FDA	Available on request
Vancomycin 1.5 g powder for injectionIntravenousGeneric name	—	US FDA	Available on request
Vancomycin 500 mg powder for injectionIntravenousGeneric name	—	US FDA	Available on request
Vancomycin 1.25 g powder for injectionIntravenousGeneric name	—	US FDA	Available on request
Vancomycin 10 g powder for injectionIntravenousGeneric name	—	US FDA	Available on request
Vancomycin 5 g powder for injectionIntravenousGeneric name	—	US FDA	Available on request
Vancomycin 750 mg powder for injectionIntravenousGeneric name	—	US FDA	Available on request
Vancomycin 1 g/200 mL injectionIntravenousGeneric name	—	US FDA	Available on request
Vancomycin 500 mg/100 mL injectionIntravenousGeneric name	—	US FDA	Available on request
Firvanq kit Cold chain	Azurity Pharmaceuticals	US FDA	Available on request
Vancomycin kit Cold chainGeneric name	—	US FDA	Available on request
Vancomycin 750 mg/150 mL injectionIntravenousGeneric name	—	US FDA	Available on request
Vancomycin 10.25 g/g powder for injectionIntravenous, oralGeneric name	—	US FDA	Available on request
Vancomycin 250 mg/5 mL oral solutionOral Cold chainGeneric name	—	US FDA	Available on request
Tyzavan 1 g/200 mL injectionIntravenous	Hikma Pharmaceuticals	US FDA	Available on request
Tyzavan 500 mg/100 mL injectionIntravenous	Hikma Pharmaceuticals	US FDA	Available on request
Tyzavan 750 mg/150 mL injectionIntravenous	Hikma Pharmaceuticals	US FDA	Available on request
Vancomycin 513 mg/mg powder for injectionIntravenous, oralGeneric name	—	US FDA	Available on request
Tyzavan 1.25 g/250 mL injectionIntravenous	Hikma Pharmaceuticals	US FDA	Available on request
Tyzavan 1.5 g/300 mL injectionIntravenous	Hikma Pharmaceuticals	US FDA	Available on request
Tyzavan 1.75 g/350 mL injectionIntravenous	Hikma Pharmaceuticals	US FDA	Available on request
Tyzavan 2 g/400 mL injectionIntravenous	Hikma Pharmaceuticals	US FDA	Available on request
Vancocin 125 mg capsuleOral	ANI Pharmaceuticals	US FDA	Available on request
Vancocin 250 mg capsuleOral	ANI Pharmaceuticals	US FDA	Available on request
Vancomycin 1.25 g powder for injectionIntravenous, oralGeneric name	—	US FDA	Available on request
Vancomycin 1.25 g/250 mL injectionIntravitreal Cold chainGeneric name	—	US FDA	Available on request
Vancomycin 1.25 g/250 mL injectionIntravenousGeneric name	—	US FDA	Available on request
Vancomycin 1.25 g/30 mL powder for injectionIntravenousGeneric name	—	US FDA	Available on request
Vancomycin 1.5 g powder for injectionIntravenous, oralGeneric name	—	US FDA	Available on request
Vancomycin 1.5 g/300 mL injectionIntravitreal Cold chainGeneric name	—	US FDA	Available on request
Vancomycin 1.5 g/300 mL injectionIntravenousGeneric name	—	US FDA	Available on request
Vancomycin 1.75 g/350 mL injectionIntravenousGeneric name	—	US FDA	Available on request
Vancomycin 10 g/95 mL powder for injectionIntravenousGeneric name	—	US FDA	Available on request
Vancomycin 100 g powder for injectionIntravenousGeneric name	—	US FDA	Available on request
Vancomycin 1025 mg/mg powder for injectionIntravenous, oralGeneric name	—	US FDA	Available on request
Vancomycin 1280 mg/mg powder for injectionIntravenous, oralGeneric name	—	US FDA	Available on request
Vancomycin 1540 mg/mg powder for injectionIntravenous, oralGeneric name	—	US FDA	Available on request
Vancomycin 2 g/400 mL injectionIntravenousGeneric name	—	US FDA	Available on request
Vancomycin 5.13 g/g powder for injectionIntravenous, oralGeneric name	—	US FDA	Available on request
Vancomycin 750 mg powder for injectionIntravenous, oralGeneric name	—	US FDA	Available on request
Vancomycin 750 mg/20 mL powder for injectionIntravenousGeneric name	—	US FDA	Available on request
Vancomycin 769 mg/mg powder for injectionIntravenous, oralGeneric name	—	US FDA	Available on request

Brands by market

3 brand names across 1 markets.

Brand names by country

United States

Firvanq Tyzavan Vancocin

Manufacturers

Regulatory status

Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.

Register	Status	Source
US FDA	First approved 15 April 1986	Drugs@FDA
EU (EMA)	Not recorded	—
India (CDSCO)	Not yet confirmed against CDSCO approval lists	—
United States	Registered	US FDA (NDC directory, openFDA)Checked 12 November 2026

Conditions

Conditions linked to Vancomycin in public data. This is not a list of approved uses, see the clinical information.

Antibiotic-associated diarrhea Bacterial infectious disease Cellulitis Ehrlichiosis Infective endocarditis Listeriosis Neutropenia Pneumonia Postoperative complications Pseudomembranous colitis Scarlet fever Septic arthritis Staphylococcal infection

Questions and answers

Is Vancomycin available for export from India?

Yes, on request. MedsAcross lists 47 presentations of Vancomycin and sources them for licensed hospitals, importers and physicians against valid import documents.

What brand names does Vancomycin have?

The catalogue lists 3 brand names for Vancomycin, including Firvanq, Tyzavan, Vancocin.

Is Vancomycin approved by the US FDA?

Yes. The US FDA first approved Vancomycin on 15 April 1986, according to Drugs@FDA.

Does Vancomycin need cold chain shipping?

At least one listed presentation of Vancomycin must be kept cold, so it is shipped in temperature-controlled packaging. Check the storage line on each presentation.

Which ATC class is Vancomycin in?

Vancomycin is classified under ATC code A07AA09 (Vancomycin).

References

vancomycin hydrochloride prescribing information (ANI Pharmaceuticals). U.S. National Library of Medicine, DailyMed. Retrieved 2 March 2026

Request Vancomycin for export supply

Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.

Request a quote Read the import guides